Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / E•••••• R•••••••

B••••••• Invests in E•••••• R•••••••

Growth investmentclosedannounced Sep 28, 2022closed Sep 28, 2022Fact
What happened
Target
E•••••• R•••••••
Platform
not an add-on on record
Control
unknown
Share acquired
unknown
Industry
healthcare / clinic, medical
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
2 named
Buy side
  • B•••••••Sponsorconfirmed
    “B••••••• completed a growth equity investment in E•••••• R•••••••, alongside members of the company's management team in September 2022. | published on Broadoak Asset's own news page broadoak.com”
Side not stated
  • E•••••• R•••••••Targetconfirmed
    “B••••••• completed a growth equity investment in E•••••• R•••••••, alongside members of the company's management team in September 2022.”
Evidence
“B••••••• completed a growth equity investment in E•••••• R•••••••, alongside members of the company's management team in September 2022.”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 19, 2026
B••••••• Invests in E•••••• R••••••• | Private Equity Intelligence | DFX